CERT
HEALTHCARECertara Inc
$6.26+0.08 (+1.29%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CERT Today?
No stock-specific AI insight has been generated for CERT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.19$13.88
$6.26
Fundamentals
Market Cap$960M
P/E Ratio—
EPS$-0.01
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume2.1M
Avg Volume (10D)—
Shares Outstanding153.3M
CERT News
22 articles- Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 7, 2026
- Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug DevelopmentYahoo Finance·May 7, 2026
- Certara (CERT) Sells Regulatory and Medical Writing Business for Up to $135MYahoo Finance·May 5, 2026
- AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, Chemaxon - Global Forecast to 2030 and 2035Yahoo Finance·Apr 29, 2026
- Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsightGlobeNewswire Inc.·Apr 27, 2026
- How The Certara (CERT) Story Is Shifting As Analysts Recut Targets And ExpectationsYahoo Finance·Apr 27, 2026
- Clinical Trial Software Research Report 2026: $2.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- Veristat to Acquire Certara’s Regulatory and Medical Writing BusinessYahoo Finance·Apr 22, 2026
- Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to VeristatYahoo Finance·Apr 22, 2026
- Cerrado Gold Announces Q1 2026 Production Results at Its Minera Don Nicolas Mine in ArgentinaYahoo Finance·Apr 20, 2026
- Certara to Report First Quarter 2026 Financial Results on May 11th, 2026Yahoo Finance·Apr 9, 2026
- How The Certara (CERT) Story Is Evolving As Price Targets Reset And Growth Plans LagYahoo Finance·Apr 8, 2026
- Cerrado Gold Announces Q4 and Annual 2025 Financial ResultsYahoo Finance·Apr 2, 2026
- Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?Yahoo Finance·Mar 20, 2026
- Is Certara (CERT) Offering Opportunity After Prolonged Share Price WeaknessYahoo Finance·Mar 15, 2026
- Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slipMarketbeat·Mar 14, 2026
- Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push BuildsMarketbeat·Mar 14, 2026
- Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen ConferenceMarketbeat·Mar 8, 2026
- Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminibYahoo Finance·Mar 3, 2026
- Assessing Certara (CERT) Valuation After Recent Share Price VolatilityYahoo Finance·Mar 1, 2026
- Certara, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Certara to Participate in Upcoming Investor ConferencesYahoo Finance·Feb 27, 2026
All 22 articles loaded
Price Data
Open$6.14
Previous Close$6.18
Day High$6.30
Day Low$6.03
52 Week High$13.88
52 Week Low$5.19
52-Week Range
$5.19$13.88
$6.26
Fundamentals
Market Cap$960M
P/E Ratio—
EPS$-0.01
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume2.1M
Avg Volume (10D)—
Shares Outstanding153.3M
About Certara Inc
Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.
HEALTHCAREHEALTH INFORMATION SERVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICHEALTH INFORMATION SERVICES
CIK—
Composite FIGI—
Share Class FIGI—